GlassScriptPhysician profile
Tung Shu
NPI 1841229523
$13,357.65
in general payments reported to CMS, 2019-2025
49 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $433 · 2021: $1,317 · 2022: $1,672 · 2023: $1,678 · 2024: $6,049 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,250 · Food and Beverage: $3,329 · Travel and Lodging: $1,575 · Education: $94.00 · Consulting Fee: $33.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,250.00 |
| Food and Beverage | $3,328.69 |
| Travel and Lodging | $1,574.96 |
| Education | $94.00 |
| Consulting Fee | $33.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $6,229.03 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Astellas Pharma US INC | $983.10 | 2019-2025 | Padcev, Myrbetriq |
| Procept Biorobotics Corporation | $733.76 | 2019-2024 | Aquabeam Robotic System, Aquabeam System |
| Pfizer INC. | $685.70 | 2019-2024 | |
| Profound Medical Corp. | $501.23 | 2021-2025 | Tulsa-Pro |
| Antares Pharma, INC. | $486.26 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $340.64 | 2020-2023 | Axonics |
| Baxter Healthcare | $282.43 | 2023-2024 | Tisseel |
| Bayer Healthcare Pharmaceuticals INC. | $224.18 | 2019-2025 | |
| Abbvie INC. | $216.30 | 2021-2023 | Botox, Lupron Depot |
| Ethicon US, LLC | $210.43 | 2021-2023 | Echelon Flex |
| Edap Technomed INC | $194.82 | 2022-2025 | |
| Biocomposites INC | $191.89 | 2024-2025 | Stimulan |
| Coloplast Corp | $190.92 | 2019-2023 | Titan |
| Sumitomo Pharma America, INC. | $186.62 | 2023-2025 | Gemtesa |
Show all 48 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tung Shu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.